BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to highlight its transition back toward oncology, outline a slate of upcoming ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

The independent journey of CureVac on public markets has concluded. The Nasdaq exchange has suspended trading of the ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...

German agrichemical giant Bayer confirmed to AFP today that it was suing American pharmaceutical firms Pfizer, Moderna and ...

Bayer is suing Pfizer, Moderna, BioNTech and Johnson & Johnson, alleging Covid-19 vaccines infringed patented mRNA technology ...

Simultaneously, a substantial legal threat has emerged. Bayer AG has filed suit against BioNTech, its partner Pfizer, and competitor Moderna. The litigation centers on patents originally developed by ...

HAMBURG, DE / / January 2, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard:EVT) today announced the appointment of Dr. Sarah Fakih as Executive Vice President, Head of Global Communications ...

A key enabler for BioNTech's ambitious plans is an exceptionally strong balance sheet, rare for a biotechnology company. As of the end of 2025, the Mainz-based firm reported liquid funds of ...

Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...

BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...

Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets Renergen Expected to Benefit from $750 million of Committed Deb ...